메뉴 건너뛰기




Volumn 59, Issue 4, 2010, Pages 325-332

Genetic markers and danger signals in Stevens-Johnson syndrome and toxic epidermal necrolysis

Author keywords

Drug hypersensitivity; Genetic polymorphism; NK cells; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; CARBAMAZEPINE; FAS LIGAND; GAMMA INTERFERON; GRANZYME B; HLA B ANTIGEN; PERFORIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

EID: 78650841781     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.10-RAI-0261     Document Type: Article
Times cited : (55)

References (70)
  • 1
    • 57349198641 scopus 로고    scopus 로고
    • Granulysin is a key mediator for disseminated keratinocyte death in Stevens- Johnson syndrome and toxic epidermal necrolysis
    • Chung WH, Hung SI, Yang JY et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens- Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008;14:1343-50
    • (2008) Nat Med , vol.14 , pp. 1343-1350
    • Chung, W.H.1    Hung, S.I.2    Yang, J.Y.3
  • 2
    • 0028243480 scopus 로고
    • The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: A clinical classification
    • Roujeau JC. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol 1994;102:28S-30.
    • (1994) J Invest Dermatol , vol.102
    • Roujeau, J.C.1
  • 3
    • 0028077408 scopus 로고
    • Severe adverse cutaneous reactions to drugs
    • Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85
    • (1994) N Engl J Med , vol.331 , pp. 1272-1285
    • Roujeau, J.C.1    Stern, R.S.2
  • 5
    • 20944452153 scopus 로고    scopus 로고
    • Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome
    • Di Pascuale MA, Espana EM, Liu DT et al. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 2005;112: 904-12
    • (2005) Ophthalmology , vol.112 , pp. 904-912
    • Di Pascuale, M.A.1    Espana, E.M.2    Liu, D.T.3
  • 7
    • 15144352793 scopus 로고    scopus 로고
    • Pulmonary complications in toxic epidermal necrolysis: A prospective clinical study
    • Lebargy F, Wolkenstein P, Gisselbrecht M et al. Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med 1997;23:1237-44.
    • (1997) Intensive Care Med , vol.23 , pp. 1237-1244
    • Lebargy, F.1    Wolkenstein, P.2    Gisselbrecht, M.3
  • 8
    • 0031671629 scopus 로고    scopus 로고
    • Toxic epidermal necrolysis with severe gastrointestinal mucosal cell death: A patient who excreted long tubes of dead intestinal epithelium
    • Sugimoto Y, Mizutani H, Sato T, Kawamura N, Ohkouchi K, Shimizu M. Toxic epidermal necrolysis with severe gastrointestinal mucosal cell death: a patient who excreted long tubes of dead intestinal epithelium. J Dermatol 1998;25:533-8
    • (1998) J Dermatol , vol.25 , pp. 533-538
    • Sugimoto, Y.1    Mizutani, H.2    Sato, T.3    Kawamura, N.4    Ohkouchi, K.5    Shimizu, M.6
  • 10
    • 0029873975 scopus 로고    scopus 로고
    • Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis
    • Paul C, Wolkenstein P, Adle H et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996;134:710-4
    • (1996) Br J Dermatol , vol.134 , pp. 710-714
    • Paul, C.1    Wolkenstein, P.2    Adle, H.3
  • 11
    • 0032538505 scopus 로고    scopus 로고
    • Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
    • Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-3
    • (1998) Science , vol.282 , pp. 490-493
    • Viard, I.1    Wehrli, P.2    Bullani, R.3
  • 12
    • 1842784823 scopus 로고    scopus 로고
    • Medical genetics: A marker for Stevens-Johnson syndrome
    • Chung WH, Hung SI, Hong HS et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004;428: 486.
    • (2004) Nature , vol.428 , pp. 486
    • Chung, W.H.1    Hung, S.I.2    Hong, H.S.3
  • 13
    • 33646934721 scopus 로고    scopus 로고
    • A marker for Stevens- Johnson syndrome...: Ethnicity matters
    • Lonjou C, Thomas L, Borot N et al. A marker for Stevens- Johnson syndrome...: ethnicity matters. Pharmacogenomics J 2006;6:265-8
    • (2006) Pharmacogenomics J , vol.6 , pp. 265-268
    • Lonjou, C.1    Thomas, L.2    Borot, N.3
  • 14
    • 61549115662 scopus 로고    scopus 로고
    • HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis
    • Kaniwa N, Saito Y, Aihara M et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2008;9:1617-22
    • (2008) Pharmacogenomics , vol.9 , pp. 1617-1622
    • Kaniwa, N.1    Saito, Y.2    Aihara, M.3
  • 15
    • 85031244783 scopus 로고    scopus 로고
    • Allele Frequencies in Worldwide Populations. Available from
    • Allele Frequencies in Worldwide Populations. Available from http://www.allelefrequencies.net/.
  • 16
    • 57449118501 scopus 로고    scopus 로고
    • Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
    • Locharernkul C, Loplumlert J, Limotai C et al. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 2008;49:2087-91
    • (2008) Epilepsia , vol.49 , pp. 2087-2091
    • Locharernkul, C.1    Loplumlert, J.2    Limotai, C.3
  • 17
    • 69749090332 scopus 로고    scopus 로고
    • Association of HLA-B*1502 with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson Syndrome in Malaysian population
    • Chang CC, Too CL, Murad S. Association of HLA-B*1502 with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson Syndrome in Malaysian population. Proceeding in 7th Asian-Oceanian Epilepsy Congress, Xiamen. 2008.
    • (2008) Proceeding In 7th Asian-Oceanian Epilepsy Congress, Xiamen
    • Chang, C.C.1    Too, C.L.2    Murad, S.3
  • 18
    • 69749108001 scopus 로고    scopus 로고
    • HLA-A, -B, -Cw, -DQA1, -DQB1 and -DRB1 alleles and KIR alleles in a Hindu population from Punjab
    • Rajalingam R, Parham P, Mehra NK. HLA-A, -B, -Cw, -DQA1, -DQB1 and -DRB1 alleles and KIR alleles in a Hindu population from Punjab, India. Human Immunology 2004;65:958-60
    • (2004) India. Human Immunology , vol.65 , pp. 958-960
    • Rajalingam, R.1    Parham, P.2    Mehra, N.K.3
  • 19
    • 70450205028 scopus 로고    scopus 로고
    • Association of HLA-B*1502 allele and carbamazepine-induced Stevens- Johnson syndrome among Indians
    • Mehta TY, Prajapati LM, Mittal B et al. Association of HLA-B*1502 allele and carbamazepine-induced Stevens- Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol 2009;75:579-82
    • (2009) Indian J Dermatol Venereol Leprol , vol.75 , pp. 579-582
    • Mehta, T.Y.1    Prajapati, L.M.2    Mittal, B.3
  • 20
    • 75649107833 scopus 로고    scopus 로고
    • HLA class I markers in Japanese patients with carbamazepineinduced cutaneous adverse reactions
    • Ikeda H, Takahashi Y, Yamazaki E et al. HLA class I markers in Japanese patients with carbamazepineinduced cutaneous adverse reactions. Epilepsia 2010;51: 297-300
    • (2010) Epilepsia , vol.51 , pp. 297-300
    • Ikeda, H.1    Takahashi, Y.2    Yamazaki, E.3
  • 21
    • 41549083321 scopus 로고    scopus 로고
    • HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese
    • Ueta M, Tokunaga K, Sotozono C et al. HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese. Mol Vis 2008;14:550-5
    • (2008) Mol Vis , vol.14 , pp. 550-555
    • Ueta, M.1    Tokunaga, K.2    Sotozono, C.3
  • 22
    • 15244349566 scopus 로고    scopus 로고
    • HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
    • U S A
    • Hung SI, Chung WH, Liou LB et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 2005; 102:4134-9
    • (2005) Proc Natl Acad Sci , vol.102 , pp. 4134-4139
    • Hung, S.I.1    Chung, W.H.2    Liou, L.B.3
  • 23
    • 70249122727 scopus 로고    scopus 로고
    • Strong association between HLA-B*5801 and allopurinolinduced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population
    • Tassaneeyakul W, Jantararoungtong T, Chen P et al. Strong association between HLA-B*5801 and allopurinolinduced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Pharmacogenet Genomics 2009;19:704-9
    • (2009) Pharmacogenet Genomics , vol.19 , pp. 704-709
    • Tassaneeyakul, W.1    Jantararoungtong, T.2    Chen, P.3
  • 24
    • 56749148531 scopus 로고    scopus 로고
    • HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions
    • Kano Y, Hirahara K, Asano Y, Shiohara T. HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions. Acta Derm Venereol 2008;88:616-8
    • (2008) Acta Derm Venereol , vol.88 , pp. 616-618
    • Kano, Y.1    Hirahara, K.2    Asano, Y.3    Shiohara, T.4
  • 25
    • 38149108354 scopus 로고    scopus 로고
    • A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
    • Lonjou C, Borot N, Sekula P et al. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 2008;18:99-107
    • (2008) Pharmacogenet Genomics , vol.18 , pp. 99-107
    • Lonjou, C.1    Borot, N.2    Sekula, P.3
  • 26
    • 0037006623 scopus 로고    scopus 로고
    • Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
    • Mallal S, Nolan D, Witt C et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002;359:727-32
    • (2002) Lancet , vol.359 , pp. 727-732
    • Mallal, S.1    Nolan, D.2    Witt, C.3
  • 27
    • 38949196447 scopus 로고    scopus 로고
    • HLA-B*5701 screening for hypersensitivity to abacavir
    • Mallal S, Phillips E, Carosi G et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008;358: 568-79
    • (2008) N Engl J Med , vol.358 , pp. 568-579
    • Mallal, S.1    Phillips, E.2    Carosi, G.3
  • 28
    • 58749103488 scopus 로고    scopus 로고
    • Should HLA-B*5701 screening be performed in every ethnic group before starting abacavir?
    • Park WB, Choe PG, Song KH et al. Should HLA-B*5701 screening be performed in every ethnic group before starting abacavir? Clin Infect Dis 2009;48:365-7
    • (2009) Clin Infect Dis , vol.48 , pp. 365-367
    • Park, W.B.1    Choe, P.G.2    Song, K.H.3
  • 29
    • 7944234979 scopus 로고    scopus 로고
    • Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells
    • Nassif A, Bensussan A, Boumsell L et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 2004;114:1209-15
    • (2004) J Allergy Clin Immunol , vol.114 , pp. 1209-1215
    • Nassif, A.1    Bensussan, A.2    Boumsell, L.3
  • 30
    • 0030822702 scopus 로고    scopus 로고
    • Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones
    • Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J Clin Invest 1997;100:136-41
    • (1997) J Clin Invest , vol.100 , pp. 136-141
    • Schnyder, B.1    Mauri-Hellweg, D.2    Zanni, M.3    Bettens, F.4    Pichler, W.J.5
  • 32
    • 0036676978 scopus 로고    scopus 로고
    • Pharmacological interaction of drugs with antigen-specific immune receptors: The p-i concept
    • Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol 2002;2:301-5
    • (2002) Curr Opin Allergy Clin Immunol , vol.2 , pp. 301-305
    • Pichler, W.J.1
  • 33
    • 0344951264 scopus 로고    scopus 로고
    • Hypersensitivity reactions to carbamazepine: Characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones
    • Naisbitt DJ, Britschgi M, Wong G et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol 2003;63:732-41
    • (2003) Mol Pharmacol , vol.63 , pp. 732-741
    • Naisbitt, D.J.1    Britschgi, M.2    Wong, G.3
  • 34
    • 34948839971 scopus 로고    scopus 로고
    • HLA-B*1502-bound peptides: Implications for the pathogenesis of carbamazepineinduced Stevens-Johnson syndrome
    • Yang CW, Hung SI, Juo CG et al. HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepineinduced Stevens-Johnson syndrome. J Allergy Clin Immunol 2007;120:870-7
    • (2007) J Allergy Clin Immunol , vol.120 , pp. 870-877
    • Yang, C.W.1    Hung, S.I.2    Juo, C.G.3
  • 35
    • 0031568384 scopus 로고    scopus 로고
    • Polymorphism in the alpha 1 helix of the HLAB heavy chain can have an overriding influence on peptide-binding specificity
    • Barber LD, Percival L, Arnett KL, Gumperz JE, Chen L, Parham P. Polymorphism in the alpha 1 helix of the HLAB heavy chain can have an overriding influence on peptide-binding specificity. J Immunol 1997;158:1660-9
    • (1997) J Immunol , vol.158 , pp. 1660-1669
    • Barber, L.D.1    Percival, L.2    Arnett, K.L.3    Gumperz, J.E.4    Chen, L.5    Parham, P.6
  • 36
    • 0023234595 scopus 로고
    • Human T cell clones use a CD3- associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity
    • David V, Bourge JF, Guglielmi P, Mathieu-Mahul D, Degos L, Bensussan A. Human T cell clones use a CD3- associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity. J Immunol 1987;138:2831-6
    • (1987) J Immunol , vol.138 , pp. 2831-2836
    • David, V.1    Bourge, J.F.2    Guglielmi, P.3    Mathieu-Mahul, D.4    Degos, L.5    Bensussan, A.6
  • 37
    • 0033956005 scopus 로고    scopus 로고
    • Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors
    • Le Cleach L, Delaire S, Boumsell L et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol 2000;119: 225-30
    • (2000) Clin Exp Immunol , vol.119 , pp. 225-230
    • Le Cleach, L.1    Delaire, S.2    Boumsell, L.3
  • 39
    • 6344225554 scopus 로고    scopus 로고
    • Evaluation of the potential role of cytokines in toxic epidermal necrolysis
    • Nassif A, Moslehi H, Le Gouvello S et al. Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Invest Dermatol 2004;123:850-5
    • (2004) J Invest Dermatol , vol.123 , pp. 850-855
    • Nassif, A.1    Moslehi, H.2    Le Gouvello, S.3
  • 40
    • 0037507304 scopus 로고    scopus 로고
    • Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions
    • Viard-Leveugle I, Bullani RR, Meda P et al. Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions. J Biol Chem 2003;278:16183-8
    • (2003) J Biol Chem , vol.278 , pp. 16183-16188
    • Viard-Leveugle, I.1    Bullani, R.R.2    Meda, P.3
  • 41
    • 0031938030 scopus 로고    scopus 로고
    • Downregulation of Fas ligand by shedding
    • Tanaka M, Itai T, Adachi M, Nagata S. Downregulation of Fas ligand by shedding. Nat Med 1998;4:31-6
    • (1998) Nat Med , vol.4 , pp. 31-36
    • Tanaka, M.1    Itai, T.2    Adachi, M.3    Nagata, S.4
  • 42
    • 0037438360 scopus 로고    scopus 로고
    • Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand
    • Knox PG, Milner AE, Green NK, Eliopoulos AG, Young LS. Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand. J Immunol 2003;170:677-85
    • (2003) J Immunol , vol.170 , pp. 677-685
    • Knox, P.G.1    Milner, A.E.2    Green, N.K.3    Eliopoulos, A.G.4    Young, L.S.5
  • 43
    • 1442351940 scopus 로고    scopus 로고
    • Kinetics and specificity of fas ligand induction in toxic epidermal necrolysis
    • Chang HY, Cooper ZA, Swetter SM, Marinkovich MP. Kinetics and specificity of fas ligand induction in toxic epidermal necrolysis. Arch Dermatol 2004;140:242-4
    • (2004) Arch Dermatol , vol.140 , pp. 242-244
    • Chang, H.Y.1    Cooper, Z.A.2    Swetter, S.M.3    Marinkovich, M.P.4
  • 44
    • 0036469109 scopus 로고    scopus 로고
    • Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas
    • Filipowicz E, Adegboyega P, Sanchez RL, Gatalica Z. Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas. Cancer 2002;94:814-9
    • (2002) Cancer , vol.94 , pp. 814-819
    • Filipowicz, E.1    Adegboyega, P.2    Sanchez, R.L.3    Gatalica, Z.4
  • 45
    • 0037407710 scopus 로고    scopus 로고
    • Toxic epidermal necrolysis and Stevens- Johnson syndrome are induced by soluble Fas ligand
    • Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H. Toxic epidermal necrolysis and Stevens- Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 2003;162:1515-20
    • (2003) Am J Pathol , vol.162 , pp. 1515-1520
    • Abe, R.1    Shimizu, T.2    Shibaki, A.3    Nakamura, H.4    Watanabe, H.5    Shimizu, H.6
  • 46
    • 0026619247 scopus 로고
    • The use of intravenous high-dose immunoglobulins (IGIV) in a case of Stevens- Johnson syndrome
    • in Italian)
    • Amato GM, Travia A, Ziino O. [The use of intravenous high-dose immunoglobulins (IGIV) in a case of Stevens- Johnson syndrome]. Pediatr Med Chir 1992;14:555-6 (in Italian).
    • (1992) Pediatr Med Chir , pp. 555-556
    • Amato, G.M.1    Travia, A.2    Ziino, O.3
  • 48
    • 0037233824 scopus 로고    scopus 로고
    • Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: A prospective noncomparative study showing no benefit on mortality or progression
    • Bachot N, Revuz J, Roujeau JC. Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 2003;139:33-6
    • (2003) Arch Dermatol , vol.139 , pp. 33-36
    • Bachot, N.1    Revuz, J.2    Roujeau, J.C.3
  • 49
    • 37349096285 scopus 로고    scopus 로고
    • Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study
    • Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol 2008;58: 33-40
    • (2008) J Am Acad Dermatol , vol.58 , pp. 33-40
    • Schneck, J.1    Fagot, J.P.2    Sekula, P.3    Sassolas, B.4    Roujeau, J.C.5    Mockenhaupt, M.6
  • 50
    • 77957055812 scopus 로고    scopus 로고
    • Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis
    • May
    • Valeyrie-Allanore L, Wolkenstein P, Brochard L et al. Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. Epub 2010 May 25.
    • (2010) Br J Dermatol. Epub , pp. 25
    • Valeyrie-Allanore, L.1    Wolkenstein, P.2    Brochard, L.3
  • 51
    • 77953592420 scopus 로고    scopus 로고
    • Severe cutaneous adverse drug reactions: Who should treat, where and how?: Facts and controversies
    • Wolf R, Davidovici B. Severe cutaneous adverse drug reactions: who should treat, where and how?: Facts and controversies. Clin Dermatol 2010;28:344-8
    • (2010) Clin Dermatol , vol.28 , pp. 344-348
    • Wolf, R.1    Davidovici, B.2
  • 52
    • 34047267273 scopus 로고    scopus 로고
    • Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome
    • Mittmann N, Chan B, Knowles S, Cosentino L, Shear N. Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Am J Clin Dermatol 2006;7:359-68
    • (2006) Am J Clin Dermatol , vol.7 , pp. 359-368
    • Mittmann, N.1    Chan, B.2    Knowles, S.3    Cosentino, L.4    Shear, N.5
  • 53
    • 0036152644 scopus 로고    scopus 로고
    • Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity
    • Posadas SJ, Padial A, Torres MJ et al. Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol 2002;109:155-61
    • (2002) J Allergy Clin Immunol , vol.109 , pp. 155-161
    • Posadas, S.J.1    Padial, A.2    Torres, M.J.3
  • 54
    • 0036230022 scopus 로고    scopus 로고
    • Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis
    • Nassif A, Bensussan A, Dorothee G et al. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. J Invest Dermatol 2002;118:728-33
    • (2002) J Invest Dermatol , vol.118 , pp. 728-733
    • Nassif, A.1    Bensussan, A.2    Dorothee, G.3
  • 55
    • 0025230476 scopus 로고
    • Perforin-mediated target cell lysis by cytolytic T lymphocytes
    • Tschopp J, Nabholz M. Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu Rev Immunol 1990;8: 279-302
    • (1990) Annu Rev Immunol , vol.8 , pp. 279-302
    • Tschopp, J.1    Nabholz, M.2
  • 56
    • 0028947976 scopus 로고
    • Perforin and granzymes: Crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity
    • Lowin B, Peitsch MC, Tschopp J. Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr Top Microbiol Immunol 1995;198:1-24
    • (1995) Curr Top Microbiol Immunol , vol.198 , pp. 1-24
    • Lowin, B.1    Peitsch, M.C.2    Tschopp, J.3
  • 57
    • 0029099845 scopus 로고
    • Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B
    • Darmon AJ, Nicholson DW, Bleackley RC. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995;377:446-8
    • (1995) Nature , vol.377 , pp. 446-448
    • Darmon, A.J.1    Nicholson, D.W.2    Bleackley, R.C.3
  • 59
    • 0343036291 scopus 로고    scopus 로고
    • Erythema multiforme and toxic epidermal necrolysis: A comparative study
    • Paquet P, Pierard GE. Erythema multiforme and toxic epidermal necrolysis: a comparative study. Am J Dermatopathol 1997;19:127-32
    • (1997) Am J Dermatopathol , vol.19 , pp. 127-132
    • Paquet, P.1    Pierard, G.E.2
  • 60
    • 0033564708 scopus 로고    scopus 로고
    • Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: Modulation by cytokines
    • Arnold R, Seifert M, Asadullah K, Volk HD. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines. J Immunol 1999;162:7140-7
    • (1999) J Immunol , vol.162 , pp. 7140-7147
    • Arnold, R.1    Seifert, M.2    Asadullah, K.3    Volk, H.D.4
  • 61
    • 0033084012 scopus 로고    scopus 로고
    • TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation
    • Zhuang L, Wang B, Shinder GA, Shivji GM, Mak TW, Sauder DN. TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J Immunol 1999;162:1440-7
    • (1999) J Immunol , vol.162 , pp. 1440-1447
    • Zhuang, L.1    Wang, B.2    Shinder, G.A.3    Shivji, G.M.4    Mak, T.W.5    Sauder, D.N.6
  • 62
    • 0033739225 scopus 로고    scopus 로고
    • High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo
    • Ruckert R, Lindner G, Bulfone-Paus S, Paus R. High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo. Br J Dermatol 2000;143:1036-9
    • (2000) Br J Dermatol , vol.143 , pp. 1036-1039
    • Ruckert, R.1    Lindner, G.2    Bulfone-Paus, S.3    Paus, R.4
  • 63
    • 0033975513 scopus 로고    scopus 로고
    • Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes
    • Leverkus M, Neumann M, Mengling T et al. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res 2000;60:553-9
    • (2000) Cancer Res , vol.60 , pp. 553-559
    • Leverkus, M.1    Neumann, M.2    Mengling, T.3
  • 64
    • 0032905030 scopus 로고    scopus 로고
    • Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB
    • Wang CY, Cusack JC Jr, Liu R, Baldwin AS Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med 1999;5:412-7
    • (1999) Nat Med , vol.5 , pp. 412-417
    • Wang, C.Y.1    Cusack Jr., J.C.2    Liu, R.3    Baldwin Jr., A.S.4
  • 66
    • 0032517486 scopus 로고    scopus 로고
    • Randomised comparison of thalidomide versus placebo in toxic epider 332
    • Lancet
    • Wolkenstein P, Latarjet J, Roujeau JC et al. Randomised comparison of thalidomide versus placebo in toxic epider 332 Allergology International Vol 59, No 4, 2010 www.jsaweb.jp/malnecrolysis. Lancet 1998;352:1586-9
    • (2010) Allergology International , vol.59 , Issue.4 , pp. 1586-1589
    • Wolkenstein, P.1    Latarjet, J.2    Roujeau, J.C.3
  • 67
    • 0032529629 scopus 로고    scopus 로고
    • Granulysin-induced apoptosis
    • I. Involvement of at least two distinct pathways
    • Gamen S, Hanson DA, Kaspar A, Naval J, Krensky AM, Anel A. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J Immunol 1998;161:1758-64
    • (1998) J Immunol , vol.161 , pp. 1758-1764
    • Gamen, S.1    Hanson, D.A.2    Kaspar, A.3    Naval, J.4    Krensky, A.M.5    Anel, A.6
  • 68
    • 0032475823 scopus 로고    scopus 로고
    • An antimicrobial activity of cytolytic T cells mediated by granulysin
    • Stenger S, Hanson DA, Teitelbaum R et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998;282:121-5
    • (1998) Science , vol.282 , pp. 121-125
    • Stenger, S.1    Hanson, D.A.2    Teitelbaum, R.3
  • 70
    • 17844405622 scopus 로고    scopus 로고
    • Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator
    • Deng A, Chen S, Li Q, Lyu SC, Clayberger C, Krensky AM. Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J Immunol 2005; 174:5243-8.
    • (2005) J Immunol , vol.174 , pp. 5243-5248
    • Deng, A.1    Chen, S.2    Li, Q.3    Lyu, S.C.4    Clayberger, C.5    Krensky, A.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.